Feldner J, Grimminger H
J Bacteriol. 1976 Apr;126(1):100-7. doi: 10.1128/jb.126.1.100-107.1976.
The mutant IP7 of Escherichia coli B requires isoleucine or pyridoxine for growth as a consequence of a mutation in the gene coding for biosynthetic threonine deaminase. The mutation of IP7 was shown to be of the nonsense type by the following data: (1) reversion to isoleucine prototrophy involves the formation of external suppression at a high frequency, as shown by transduction experiments; and (ii) the isoleucine requirement is suppressed by lysogenization with a phage carrying the amber suppressor su-3. Cell extracts of the mutant strain contain a low activity of threonine deaminase. The possibility that this activity is biodegradative was ruled out by kinetic experiments. The mutant threonine deaminase was purified to homogeneity by conventional procedures. The enzyme is a dimer of identical subunits of an approximate molecular weight of 43,000 (Grimminger and Feldner, 1974), whereas the wild-type enzyme is a tetramer of 50,000-dalton subunits (Calhoun et al., 1973; Grimminger et al., 1973). The mutant enzyme is not inhibited by isoleucine and does not bind isoleucine, as shown by equilibrium dialysis experiments. Pyridoxal phosphate enhances the maximum catalytic activity of the mutant enzyme by a factor of five, whereas the wild-type enzyme is not affected. In wild-type and mutant threonine deaminase the ratio of protein subunits and bound pyridoxal phosphate is 2:1. The activation of threonine deaminase from strain IP7 is due to a second coenzyme binding site, as shown by (i) spectrophotometric titration of the enzyme with pyridoxal phosphate and by (ii) measurement the pyridoxal phosphate content of the enzyme after sodium borohydride reduction of the protein. The observation of one pyridoxal phosphate binding site per peptide dimer in the wild-type enzyme and of two binding sites per dimer in the mutant strongly suggests that one of the potential sites in the wild-type enzyme is masked by allosteric effects. The factors responsible for the half-of-the-sites reactivity of the coenzyme sites appear to be nonoperative in the mutant protein.
大肠杆菌B的突变体IP7由于编码生物合成苏氨酸脱氨酶的基因突变,生长需要异亮氨酸或吡哆醇。以下数据表明IP7的突变属于无义突变类型:(1)回复到异亮氨酸原养型涉及高频形成外部抑制,如转导实验所示;(ii)携带琥珀抑制基因su-3的噬菌体溶原化可抑制对异亮氨酸的需求。突变菌株的细胞提取物中苏氨酸脱氨酶活性较低。动力学实验排除了这种活性是生物降解性的可能性。通过常规方法将突变型苏氨酸脱氨酶纯化至同质。该酶是由近似分子量为43,000的相同亚基组成的二聚体(格林明格和费尔德纳,1974年),而野生型酶是由50,000道尔顿亚基组成的四聚体(卡尔霍恩等人,1973年;格林明格等人,1973年)。平衡透析实验表明,突变酶不受异亮氨酸抑制,也不结合异亮氨酸。磷酸吡哆醛使突变酶的最大催化活性提高了五倍,而野生型酶不受影响。在野生型和突变型苏氨酸脱氨酶中,蛋白质亚基与结合的磷酸吡哆醛的比例均为2:1。如(i)用磷酸吡哆醛对酶进行分光光度滴定以及(ii)在蛋白质经硼氢化钠还原后测量酶的磷酸吡哆醛含量所示,菌株IP7的苏氨酸脱氨酶的激活是由于第二个辅酶结合位点。在野生型酶中每个肽二聚体观察到一个磷酸吡哆醛结合位点,而在突变体中每个二聚体观察到两个结合位点,这强烈表明野生型酶中一个潜在位点被变构效应掩盖。辅酶位点半位点反应性的相关因素在突变蛋白中似乎不起作用。